Our technology

Do not underestimate the importance of a clinic’s technology when reviewing success rates and aspiring to one cycle, one family. Genea’s exclusive world leading incubation system has seen an increase of 46.7% in the number of high grade embryos per cycle^^, supporting our goal of creating more embryos from just one egg collection.

Our Leading Science 
Genea Geri in lab image

Our history

Genea has long been a fertility pioneer with our research and technologies virtually doubling IVF success rates for patients in the mid-nineties. Our constant search for innovations and breakthroughs continues to improve outcomes today.

our experience
Our history image

Our care

Genea offers a range of fertility treatments, not just IVF. In fact only 50% of patients who see a Genea Fertility Specialist require IVF. Our unique care model means you have a dedicated fertility care team comprising of fertility specialists, nurses, scientists and counsellors, all tailoring your treatment for you. Care is in our DNA.

Why Genea
Genea mum and baby

Of those patients who responded to the Genea patient survey conducted between 1 January 2017 and 31 December 2017 (223 patients).
1st Stim Cycle between 01Jan12-31Dec13 (3573 patients). Following subsequent Cryos through to 31Dec15. Autologous patients only (no donor oocytes or surrogates). Sites from Kent St, Liverpool, Canberra, Norwest/Bella Vista, Illawarra. Oocyte Vitrification patients excluded.
^^ When compared to the traditional incubator and culture medium system. Study performed at Genea’s flagship Kent Street, Sydney CBD laboratory. Data presented at Fertility Society of Australia Conference, October 2017. Adelaide.